FDA
-
-
-
-
-
-
-
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
-
-
-
-
-
-
-
NanoString Appoints Don Kania, Ph.D. to its Board of Directors
-
-
-
-
-
-
-
New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
-
-
-
-
-
-
-
NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
-
-
-
-
-
-
-
NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis
-
-
-
-
-
-
-
NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
-
-
-
-
-
-
-
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualifie
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

